Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional Study
ConclusionThe correct administration of romiplostim by most patients/caregivers supports the effectiveness of the HAT pack as an additional risk minimisation tool in the population and setting of this study.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Study | Thrombocytopenia | Training | Universities & Medical Training